Announced Tue, 7 Jul · 15:23 IST
Quarterly compliance certificate for share dematerialization, June 2026
Compliance View source PDF
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-5.2%1-day move
₹35.24
prior close
—
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
————-5.2-4.1-0.7-3.8-4.8-4.9————
Up moveDown movePending
AI summary
Pharmaids Pharmaceuticals filed a routine quarterly compliance certificate under SEBI Regulation 74(5) for the quarter ended June 30, 2026. The company submitted the certificate received from its Registrar, Venture Capital and Corporate Investments, confirming that shares received for dematerialization have been cancelled after verification and that NSDL and CDSL records have been updated as registered owners within the 15-day window. This is a standard procedural filing.
Likely market impact
Routine regulatory compliance filing. No material impact on business or shareholders.